Medical technology company Smith+Nephew has received an Innovative Technology contract from Vizient to supply its PICO single-use negative pressure wound therapy (sNPWT) system.

PICO is a portable, easy-to-use, canister-free sNPWT system equipped with the Smith+Nephew soft port technology.

The silicone-based, four-layer technology is designed to manage exudate from wounds by simultaneously evaporating and locking it away

This removes extra moisture away from the wound and peri-wound area.

Furthermore, the technology provides compression to the peri-wound area, potentially improving tissue perfusion.

Smith+Nephew NPWT vice-president and general manager Laura Ackerman said: “We are thrilled that our PICO System has been recognised by healthcare experts in receiving this distinguished Innovative Technology contract in the US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Surgical site complications continue to be costly events that plague our patients and healthcare systems. Our PICO technology has been shown to reduce the risk of SSIs across multiple specialities, improving patient care and helping get them home sooner.”

In January last year, the PICO system was approved by the US Food and Drug Administration for new indications.

The system became the first sNPWT system indicated to assist in reducing the incidence of wound complications such as superficial and deep incisional surgical site infections (SSIs) for Class I and Class II wounds, post-operative seroma and dehiscence.

Healthcare-performance-improvement company Vizient was awarded the contract based on recommendations by hospital experts who are part of its member-led councils.

The PICO system is expected to bring potential improvement to the healthcare industry.

Vizient awards Innovative Technology contracts after review and interaction with products submitted through its Innovative Technology Program.

The programme works with members and suppliers to identify technologies that have the potential to improve clinical care, patient safety and healthcare worker safety or enhance the business model for healthcare organisations.